A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)
Metadata only so far. Questions are answered only with quotes from this document. Source: ClinicalTrials.gov, retrieved 2026-11-04.
Ongoing
Record metadata
- Phase
- Phase 3
- Status
- Not yet recruiting
- Start
- 2026-02
- End
- 2028-07
- Enrollment
- 198
- Sites
- 0
- Sponsor class
- OTHER
Not in the data yet: a trial card. A one-glance card (population, design, endpoints, result, each tied to a quote) is not built yet. The fields above are registry or bibliographic metadata, not quotes.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you get that instead of a guess.
Source text
No passages are loaded for this document yet.